Faldaprevir plus interferon and ribavirin cures hepatitis C in most people with HIV/HCV co-infection

The hepatitis C protease inhibitor faldaprevir added to pegylated interferon and ribavirin cured hepatitis C in nearly three-quarters of people with genotype 1 hepatitis C virus and HIV co-infection in the STARTVerso4 trial, equaling response rates for people with hepatitis C alone, according to a report at the 21st Conference on Retroviruses and ... (more)

http://ift.tt/1doOsOt